Securities ▲▼ | Shares | Value | |||||
|---|---|---|---|---|---|---|---|
Q1 2025 ▲▼ | Q2 2025 ▲▼ | Change ▲▼ | Q1 2025 ▲▼ | Q2 2025 ▲▼ | Weight (%) ▲▼ | Change ▲▼ | |
| Pharvaris N V COM | 4,289,304 | 4,289,304 | 0 | $67.34M | $75.49M | 65.78% | +$8.15M |
| Harmony Biosciences Holdings, Inc.(HRMY) | 489,194 | 489,194 | 0 | $16.24M | $15.46M | 13.47% | -$777.8K |
| Alumis Inc | 2,787,398 | 4,619,803 | +1,832,405 | $17.11M | $13.86M | 12.08% | -$3.26M |
| Lyell Immunopharma, Inc.(LYEL) | 0 | 473,479 | +473,479 | $0 | $4.19M | 3.65% | +$4.19M |
| ALX Oncology Holdings Inc.(ALXO) | 9,699,925 | 9,699,925 | 0 | $6.04M | $4.03M | 3.51% | -$2.02M |
| Artiva Biotherapeutics, Inc.(ARTV) | 1,198,975 | 1,148,975 | -50,000 | $3.60M | $1.73M | 1.51% | -$1.86M |
| Acelyrin Inc | 3,806,410 | 0 | -3,806,410 | $9.40M | $0 | — | -$9.40M |
| Lyell Immunopharma, Inc.(LYEL) | 7,102,190 | 0 | -7,102,190 | $3.82M | $0 | — | -$3.82M |